Your browser doesn't support javascript.
loading
Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.
Li, Chung-Yen; Anuraga, Gangga; Chang, Chih-Peng; Weng, Tzu-Yang; Hsu, Hui-Ping; Ta, Hoang Dang Khoa; Su, Pei-Fang; Chiu, Pin-Hsuan; Yang, Shiang-Jie; Chen, Feng-Wei; Ye, Pei-Hsuan; Wang, Chih-Yang; Lai, Ming-Derg.
Afiliación
  • Li CY; College of Medicine, Institute of basic medical sciences, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Anuraga G; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan, ROC.
  • Chang CP; Department of Statistics, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya, Indonesia.
  • Weng TY; College of Medicine, Institute of basic medical sciences, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Hsu HP; Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Ta HDK; College of Medicine, Institute of basic medical sciences, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Su PF; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Chiu PH; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan, ROC.
  • Yang SJ; Department of Statistics, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Chen FW; The Center for Quantitative Sciences, Clinical Medicine Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Ye PH; College of Medicine, Institute of basic medical sciences, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Wang CY; College of Medicine, Institute of basic medical sciences, National Cheng Kung University, Tainan, Taiwan, ROC.
  • Lai MD; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
J Exp Clin Cancer Res ; 42(1): 22, 2023 Jan 14.
Article en En | MEDLINE | ID: mdl-36639681
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Linfocitos T CD8-positivos Límite: Animals Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma / Linfocitos T CD8-positivos Límite: Animals Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido